Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025

                    Revenue
                    FY2025
                
$6.9B
                    3y CAGR +0.5%
                    
                    P17
                    
                    +6.7%
                    
                    Net income
                    FY2025
                
$1.3B
                    Net margin +18.8%
                    
                    P77
                    
                    +1.1%
                    
                    Total assets
                    FY2025
                
$12.7B
                    ROA +10.2%
                    
                    P72
                    
                    +7.4%
                    
                    Operating cash flow
                    FY2025
                
$1.6B
                    FCF margin +16.6%
                    
                    P55
                    
                    -11.0%

20 yrs · FY2006–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Year-over-year change per cell; first column has no prior.

Balance Sheet

Assets, liabilities, and equity

31 accounts · 3 years

Total assets $12.7B

Total liabilities $6.0B

Shareholders equity $6.7B

Account	2025	2024	2023
Assets
Cash and Cash Equivalents	+34.6%	-16.4%	—
Short Term Investments	—	—	—
Accounts Receivable	+12.3%	+2.6%	—
Inventory	+5.5%	-5.7%	—
Prepaid Expenses	-12.3%	+21.9%	—
Other Current Assets	-12.3%	+21.9%	—
Total Current Assets	+16.0%	-5.4%	—
Property,Plant and Equipment	+13.8%	+40.0%	—
Operating Lease Assets	+3.4%	+14.9%	—
Goodwill	-0.1%	+13.1%	—
Intangible Assets	-18.6%	+15.2%	—
Long Term Investments	-24.0%	+6.7%	—
Other Noncurrent Assets	+16.4%	+28.5%	—
Total Assets	+7.4%	+10.1%	—
Liabilities
Accounts Payable	+5.6%	+29.2%	—
Accrued Liabilities	-14.8%	+17.1%	—
Deferred Revenue	+14.7%	+7.7%	—
Current Portion of Long Term Debt	+575.6%	—	—
Total Current Liabilities	+23.9%	+18.2%	—
Long Term Debt	-8.8%	+22.3%	—
Deferred Revenue Noncurrent	+14.7%	+7.7%	—
Other Noncurrent Liabilities	-19.9%	+21.2%	—
Total Liabilities	+0.6%	+20.9%	—
Equity
Preferred Stock	—	—	—
Common Stock	+0.0%	+0.0%	—
Additional Paid In Capital	+2.3%	+1.2%	—
Retained Earnings	+85.2%	-4.1%	—
Treasury Stock	—	—	—
Accumulated Other Comprehensive Income	+25.9%	+6.7%	—
Total Stockholders Equity	+14.3%	+0.9%	—
Total Liabilitiesand Equity	+7.4%	+10.1%	—

Income Statement

Revenue, expense, and profitability

20 accounts · 3 years

Revenue $6.9B

Operating income $1.5B

Net income $1.3B

Account	2025	2024	2023
IncomeStatement
Revenues Total Revenue	+6.7%	-4.7%	—
Expenses Cost of Revenue	+11.1%	-11.7%	—
Expenses Research and Development	-5.0%	-0.4%	—
Expenses Selling,General and Administrative	+9.0%	-4.0%	—
Expenses Depreciation and Amortization	+12.1%	-5.2%	—
Expenses Share Based Compensation	-0.8%	+16.2%	—
Expenses Restructuring and Asset Impairment	+7.9%	+65.2%	—
Expenses Operating Expenses	+8.9%	-8.4%	—
Other Income Expense Operating Income	-0.6%	+10.2%	—
Other Income Expense Interest Income	-22.5%	+56.9%	—
Other Income Expense Interest Expense	+16.7%	+1.1%	—
Other Income Expense Other Income/expense	-87.8%	+48.5%	—
Other Income Expense Income Before Tax	-5.7%	+13.6%	—
Income Tax Income Tax Expense	-43.1%	+134.3%	—
net Income net Income	+1.1%	+4.0%	—
net Income Comprehensive Income	+5.4%	+4.0%	—
Earnings Per Share Basic Eps	+3.4%	+5.2%	—
Earnings Per Share Diluted Eps	+3.2%	+5.7%	—
Earnings Per Share Weighted Average Shares Basic	-2.1%	-1.4%	—
Earnings Per Share Weighted Average Shares Diluted	-2.1%	-1.7%	—

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 3 years

Operating cash flow $1.6B

Investing cash flow $-394.0M

Financing cash flow $-715.0M

Account	2025	2024	2023
CashFlow
Operating Activities net Income	+1.1%	+4.0%	—
Operating Activities Depreciation and Amortization	+12.1%	-5.2%	—
Operating Activities Stock Based Compensation	-0.8%	+16.2%	—
Operating Activities Deferred Income Taxes	-103.1%	-14.3%	—
Operating Activities Changes In Operating Assets and Liabilities	+59.6%	+174.7%	—
Operating Activities net Cash From Operating Activities	-11.0%	-1.2%	—
Investing Activities Capital Expenditures	+7.7%	+26.8%	—
Investing Activities Business Acquisitions	-100.5%	+1590.2%	—
Investing Activities Purchases of Investments	-100.0%	-37.5%	—
Investing Activities net Cash From Investing Activities	+68.7%	-305.8%	—
Financing Activities Proceeds From Debt	-99.7%	—	—
Financing Activities Repayment of Debt	-99.5%	—	—
Financing Activities Repurchase of Common Stock	-63.0%	+100.0%	—
Financing Activities Dividends Paid	+2.9%	+3.4%	—
Financing Activities Proceeds From Stock Issuance	-6.5%	+14.9%	—
Financing Activities Tax Withholding On Stock Based Compensation	-3.3%	-44.4%	—
Financing Activities Other Financing Activities	—	—	—
Financing Activities net Cash From Financing Activities	+4.9%	+19.1%	—
Cash Reconciliation Effect of Exchange Rate On Cash	+550.0%	-140.0%	—
Cash Reconciliation net Change In Cash	+275.9%	-148.6%	—
Cash Reconciliation Cash At Beginning of Period	+34.5%	-16.4%	—
Cash Reconciliation Cash At End of Period	+34.5%	-16.4%	—

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years

Ratio	2025	2024	2023
Profitability
Gross margin	+52.4%	+54.3%	+50.7%
Operating margin	+21.3%	+22.9%	+19.8%
Net margin	+18.8%	+19.8%	+18.1%
FCF margin	+16.6%	+21.1%	+21.6%
Growth
Revenue CAGR (3y)	+0.5%	+1.0%	+8.6%
Returns
ROE	+19.3%	+21.9%	+21.2%
ROA	+10.2%	+10.9%	+11.5%
ROIC	+16.2%	+15.8%	+17.9%
Liquidity
Current ratio	1.96x	2.09x	2.61x
Quick ratio	1.40x	1.40x	1.80x
Leverage
D/E	0.89x	1.01x	0.84x
Interest coverage	13.21x	15.50x	14.21x
Efficiency
Asset turnover	0.55x	0.55x	0.63x
Cash conversion cycle	+128d	+127d	+135d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 166d old · FY2025

Market cap $32.9B

P/E 25.26x

P/S 4.74x

P/B 4.88x

EV $34.5B

EV/EBITDA 19.51x

FCF yield +3.5%

Dividend yield +0.9%

Notes

Your annotations

Not watched